DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
about
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis.A Review of Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide and Its DerivativesCharacterization of the Contribution of Genetic Background and Gender to Disease Progression in the SOD1 G93A Mouse Model of Amyotrophic Lateral Sclerosis: A Meta-Analysis.DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model.Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosisComparison of Two Old Phytochemicals versus Two Newly Researched Plant-Derived Compounds: Potential for Brain and Other Relevant Ailments.Apium graveolens extract influences mood and cognition in healthy mice.Nrf2 as a target for prevention of age-related and diabetic cataracts by against oxidative stress.The Dual Role of Microglia in ALS: Mechanisms and Therapeutic Approaches.Dl-3-n-Butylphthalide Treatment Enhances Hemodynamics and Ameliorates Memory Deficits in Rats with Chronic Cerebral Hypoperfusion.Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications.Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Dl-3-n-butylphthalide attenuates acute inflammatory activation in rats with spinal cord injury by inhibiting microglial TLR4/NF-κB signalling.Dl-3-n-butylphthalide prevents the disruption of blood-spinal cord barrier via inhibiting endoplasmic reticulum stress following spinal cord injury.Dl-3n-butylphthalide reduces epileptiform activity through GluA2-lacking calcium-permeable AMPARs in epilepsy models.TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury.Effects of Dl-3-n-butylphthalide on Cerebral Ischemia Infarction in Rat Model by Mass Spectrometry Imaging.n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis.DL-3-n-Butylphthalide (NBP) Provides Neuroprotection in the Mice Models After Traumatic Brain Injury via Nrf2-ARE Signaling Pathway.The therapeutic effect of (DL)-3-n-butylphthalide in rats with chronic cerebral hypoperfusion through downregulation of amyloid precursor protein and matrix metalloproteinase-2.L-3-n-Butylphthalide attenuates neuroinflammatory responses by downregulating JNK activation and upregulating Heme oxygenase-1 in lipopolysaccharide-treated mice.Effect of butylphthalide intervention on experimental autoimmune myositis in guinea pigs.Electric Stimulation of Ear Reduces the Effect of Toll-Like Receptor 4 Signaling Pathway on Kainic Acid-Induced Epileptic Seizures in Rats.
P2860
Q24613709-A02A5B74-09FE-472C-B88F-FD58604524FCQ33801090-B01DF515-2361-460E-A48C-971F360B1653Q34548561-B00D9A3A-27D7-4FE7-A65D-F697F209B7D5Q36299228-E272B5F7-E43A-4923-9F92-FF59A2C2CBB1Q36497828-14263381-C441-4573-B30D-00029F00B70AQ36732766-4FABD2EE-7AB8-4636-AB22-D64F3C8B206FQ37732981-6E77156D-2EE7-461D-B5DC-1A7CAEA56088Q38221853-B100EE82-A5C0-43B0-AB74-BB7633BDA236Q38958470-C6E1A148-9CD1-4358-9A05-230639D7CF47Q39443773-36680931-949F-4A1F-A0C0-2A62590EB596Q41107984-B9839CB5-1A8C-4AC7-9702-9216931086D5Q41123114-4486B015-6FE2-471C-BD65-C440B434D5F3Q41488070-DA28FE14-A7DF-49D9-B053-28D852504FBBQ41662736-EE9C69E5-0308-4898-901C-31C144A4D0CAQ45732351-6F1AEA41-0A36-4F60-AFF4-C6BDA548533CQ47101702-C1E036ED-08FA-42A4-B616-5AA3A5F8B170Q47104829-EA342756-8BF3-4961-885A-FF3FC3E3D181Q47736299-E5694EC8-5A3A-4B98-9B5F-B461C780B1BDQ47955339-DD0F5223-DC02-417B-80A0-732A4045A75AQ48204504-105C9A0A-7B14-4E06-9F34-3D68773B7D03Q48302548-861A3709-4DD9-4B77-9B45-06041F1BC3D8Q48404367-909E1EC3-859A-4551-9C7E-EE17DAA1DF48Q49139575-04BD4A8A-652D-47D5-8C08-C8C6965CABBDQ49221760-15D37914-04FB-432E-91BF-DDDEABD6FB4BQ54114873-9983AB3D-F4C0-4003-AC60-CB9D4F8188E6
P2860
DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@ast
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@en
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@nl
type
label
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@ast
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@en
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@nl
prefLabel
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@ast
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@en
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@nl
P2093
P1433
P1476
DL-3-n-butylphthalide extends ...... amyotrophic lateral sclerosis.
@en
P2093
Liying Cui
Mingsheng Liu
Xinhong Feng
P304
P356
10.1016/J.NEUROPHARM.2011.10.009
P577
2011-11-02T00:00:00Z